Federal Register / Vol. 86, No. 175 / Tuesday, September 14, 2021 / Notices 51159 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form name Number of 

Respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

Total ........................................... ........................................................... ........................ ........................ ........................ 11,741 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–19753 Filed 9–13–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–1039] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Information 

Collection on Cause-Specific 

Absenteeism in Schools to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on March 1, 

2021 to obtain comments from the 

public and affected agencies. CDC 

received and replied to two nonsubstantive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Information Collection on CauseSpecific Absenteeism in Schools (OMB 

Control No. 0920–1039)—Reinstatement 

with Change—National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The Information Collection on CauseSpecific Absenteeism in Schools aims to 

improve; (1) understanding of the role of 

influenza-like illness (ILI)-specific 

absenteeism in schools in predicting 

community-wide influenza 

transmission, and (2) to detect withinhousehold transmission of influenza in 

households from which a student has 

been absent from school due to ILI. 

Due to children’s naı ̈ve immunity, 

their susceptibility to infectious 

diseases, and congregation of children at 

schools, schools serve as amplification 

points for influenza transmission. 

Therefore, the collection of ILI-specific 

absenteeism could provide information 

needed to detect influenza outbreaks 

early, before infection spreads to a 

wider community. Such early detection 

of outbreaks will enable public health 

and school authorities to implement 

appropriate infection control and 

prevention measures. 

School children are frequently the 

main introducers of influenza to their 

families. Evaluating influenza 

transmission within households where 

students are absent from school because 

of ILI may serve as an additional layer 

of influenza surveillance, and could 

contribute to understanding of influenza 

transmission dynamics within the 

surrounding community. Insights 

gained from this information collection 

will be used to strengthen the evidencebase of CDC’s Pre-Pandemic Guidance 

prior to the next pandemic. 

Since obtaining OMB approval in 

December 2014, 2,466 Oregon School 

District students with ILI have been 

enrolled in the study. Of them, 68% 

were positive for at least one respiratory 

pathogen included in the PCR panel that 

tests for presence of 17 common 

respiratory viruses, and 29% of students 

were found to be positive for influenza. 

It was demonstrated that absenteeism 

due to ILI in school children was highly 

correlated with PCR-confirmed 

influenza in enrolled school children, 

and medically-attended influenza in the 

surrounding community, suggesting that 

ILI-specific school absenteeism can be 

considered a useful tool for predicting 

influenza outbreaks in the surrounding 

community. For all six seasons, (2015– 

2021) significant, positive crosscorrelations were achieved for 

absenteeism due to illness (a–I) and 

absenteeism due to ILI (a–ILI) at least 14 

days in advance of MAI. Further 

observations during influenza seasons 

caused by other influenza strains are 

needed to make these findings more 

robust. 

In the currently approved information 

collection, information and 

biospecimens are collected only from 

students who were absent from school 

because of ILI. This reinstatement with 

change to the currently approved 

information collection adds a household 

transmission component, in which 

information and biospecimens will be 

collected from household members of 

students absent from school because of 

ILI. This aims to enhance current 

knowledge and understanding around 


tkelley on DSK125TN23PROD with NOTICES
51160 Federal Register / Vol. 86, No. 175 / Tuesday, September 14, 2021 / Notices 

the introduction of influenza infection 

to households that have school-age 

children, as well as within-household 

influenza transmission. 

CDC requests approval for 434 annual 

burden hours. There is no cost to 

respondents other than their time to 

participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Parents of children/adolescents or adult students (≥18 yo) attending schools.Screening Form .............................................. 345 1 5/60 

Acute Respiratory Infection and Influenza 

Surveillance Form.

300 1 15/60 

Household Study Form A ............................... 300 1 5/60 

Student ............................................................ Biospecimen collection (Day 0) ..................... 300 1 5/60 

Parents of children/adolescents or adult students (≥18 yo) attending schools.Household Study Form B (Day 7 and 14) ..... 240 1 5/60 

Student ............................................................ Biospecimen collection (Day 7 and 14) ......... 240 1 5/60 

Household members ....................................... Household Study Form B (Day 0, 7 and 14) 720 2 5/60 

Household members ....................................... Biospecimen collection (Day 0, 7 and 14) ..... 720 2 5/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–19754 Filed 9–13–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Biodefense Science Board 

AGENCY: Office of the Assistant 

Secretary for Preparedness and 

Response (ASPR), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The National Biodefense 

Science Board (NBSB or the Board) is 

authorized under Section 319M of the 

Public Health Service (PHS) Act, as 

added by Section 402 of the Pandemic 

and All-Hazards Preparedness Act of 

2006 and amended by Section 404 of the 

Pandemic and All-Hazards 

Preparedness Reauthorization Act. The 

Board is governed by the Federal 

Advisory Committee Act, which sets 

forth standards for the formation and 

use of advisory committees. The NBSB 

provides expert advice and guidance on 

scientific, technical, and other matters 

of special interest to the Department 

regarding current and future chemical, 

biological, nuclear, and radiological 

agents, whether naturally occurring, 

accidental, or deliberate. 

DATES: The NBSB will meet in public 

(virtually) on September 28, 2021, to 

discuss high priority issues related to 

national public health emergency 

preparedness and response. A more 

detailed agenda will be available on the 

NBSB meeting website https://

www.phe.gov/nbsb. 

ADDRESSES: Members of the public may 

attend the meeting via a toll-free phone 

number or Zoom teleconference, which 

requires pre-registration. The meeting 

link to pre-register will be posted on 

https://www.phe.gov/nbsb. Members of 

the public may provide written 

comments or submit questions for 

consideration by the NBSB at any time 

via email to NBSB@hhs.gov. Members of 

the public are also encouraged to 

provide comments after the meeting. 

FOR FURTHER INFORMATION CONTACT: 

CAPT Christopher L. Perdue, MD, MPH, 

NBSB Designated Federal Officer, 

Washington, DC, Office, 202–401–5837, 

NBSB@hhs.gov. 

SUPPLEMENTARY INFORMATION: The NBSB 

invites those who are involved in or 

represent a relevant industry, academia, 

health profession, health care consumer 

organization, or state, Tribal, territorial 

or local government to request up to 

seven minutes to address the board in 

person via Zoom. Requests to provide 

remarks to the NBSB during the public 

meeting must be sent to NBSB@hhs.gov 

at least 15 days prior to the meeting 

along with a brief description of the 

topic. We would specifically like to 

request inputs from the public on 

challenges, opportunities, and strategic 

priorities for national health security 

and biodefense. Presenters who are 

selected for the public meeting will 

have audio only during the meeting. 

Slides, documents, and other 

presentation material sent along with 

the request to speak will be provided to 

the board members separately. Please 

indicate additionally whether the 

presenter will be willing to take 

questions from the board members (at 

their discretion) immediately following 

their presentation (for up to seven 

additional minutes). 

Dawn O’Connell, 

Assistant Secretary for Preparedness and 

Response. 

[FR Doc. 2021–19789 Filed 9–13–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Ninth Amendment to Declaration 

Under the Public Readiness and 

Emergency Preparedness Act for 

Medical Countermeasures Against 

COVID–19 

ACTION: Notice of amendment. 

SUMMARY: The Secretary issues this 

amendment pursuant to section 319F–3 

of the Public Health Service Act to 

expand the authority for certain 

Qualified Persons authorized to 

prescribe, dispense, and administer 

COVID–19 therapeutics that are covered 

countermeasures under section VI of 

this Declaration. 

DATE: This amendment is effective as of 

September 14, 2021. 

FOR FURTHER INFORMATION CONTACT: L. 

Paige Ezernack, Office of the Assistant 

Secretary for Preparedness and 

Response, Office of the Secretary, 

Department of Health and Human 

Services, 200 Independence Avenue 

SW, Washington, DC 20201; 202–260– 

0365, paige.ezernack@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Public Readiness and Emergency 

Preparedness Act (PREP Act) authorizes 


tkelley on DSK125TN23PROD with NOTICES